Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSadler, Evan-
dc.date.accessioned2012-04-18T14:38:02Z-
dc.date.available2012-04-18T14:38:02Z-
dc.date.issued2012-04-18T14:38:02Z-
dc.identifier.urihttp://hdl.handle.net/2451/31541-
dc.description.abstractIn his discussion of minimax decision rules, Savage (1954, p. 170) presents an example purporting to show that minimax applied to negative expected utility (referred to by Savage as 'negative income') is an inadequate decision criterion for statistics; he suggests the application of a minimax regret rule instead. The crux of Savage's objection is the possibility that a decision maker would choose to ignore even 'extensive' information. More recently, Parmigiani (1992) has suggested that minimax regret suffers from the same flaw. He demonstrates the existence of 'relevant' experiments that a minimax regret agent would never pay a positive cost to observe. On closer inspection, I find that minimax regret is more resilient to this critique than would first appear. In particular, there are cases where no experiment has any value to an agent employing the minimax negative income rule, while we may always devise a hypothetical experiment that a minimax regret agent would pay for. The force of Parmigiani's critique is further blunted by the observation that 'relevant' experiments exist for which a Bayesian agent would never pay. I conclude by discussing the notion of pessimism in the context of minimax decision rules.en
dc.description.sponsorshipNYU Stern School of Business; Department of Information, Operations and Management Sciencesen
dc.languageEnglishEN
dc.language.isoen_USen
dc.publisherStern School of Business, New York UniversityEN
dc.relation.ispartofseries;SOR-2012-01-
dc.titleMinimax and the Value of Informationen
dc.typeWorking Paperen
dc.description.seriesStatistics Working Papers SeriesEN
dc.authorid-ssrn20784en
Appears in Collections:IOMS: Statistics Working Papers

Files in This Item:
File Description SizeFormat 
Minimax and Information.pdf218.23 kBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.